167 related articles for article (PubMed ID: 32771251)
21. The impact of surgery in molecularly defined low-grade glioma: an integrated clinical, radiological, and molecular analysis.
Wijnenga MMJ; French PJ; Dubbink HJ; Dinjens WNM; Atmodimedjo PN; Kros JM; Smits M; Gahrmann R; Rutten GJ; Verheul JB; Fleischeuer R; Dirven CMF; Vincent AJPE; van den Bent MJ
Neuro Oncol; 2018 Jan; 20(1):103-112. PubMed ID: 29016833
[TBL] [Abstract][Full Text] [Related]
22. Progressive Low-Grade Glioma: Assessment of Prognostic Importance of Histologic Reassessment and MRI Findings.
Narang AK; Chaichana KL; Weingart JD; Redmond KJ; Lim M; Olivi A; Quinones-Hinojosa A; Kleinberg LR
World Neurosurg; 2017 Mar; 99():751-757. PubMed ID: 27108796
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of prognostic factors on survival in patients with low grade glioma.
Durmaz R; Vural M; Işildi E; Coşan E; Ozkara E; Bal C; Ciftçi E; Arslantaş A; Atasoy MA
Turk Neurosurg; 2008 Oct; 18(4):336-44. PubMed ID: 19107679
[TBL] [Abstract][Full Text] [Related]
24. Is there a risk of seizures in "preventive" awake surgery for incidental diffuse low-grade gliomas?
Lima GL; Duffau H
J Neurosurg; 2015 Jun; 122(6):1397-405. PubMed ID: 25723301
[TBL] [Abstract][Full Text] [Related]
25. Identifying clinical risk in low grade gliomas and appropriate treatment strategies, with special emphasis on the role of surgery.
Boissonneau S; Duffau H
Expert Rev Anticancer Ther; 2017 Aug; 17(8):703-716. PubMed ID: 28608763
[TBL] [Abstract][Full Text] [Related]
26. Observation after surgery for low grade glioma: long-term outcome in the light of the 2016 WHO classification.
Jansen E; Hamisch C; Ruess D; Heiland DH; Goldbrunner R; Ruge MI; Schnell O; Grau SJ
J Neurooncol; 2019 Dec; 145(3):501-507. PubMed ID: 31621043
[TBL] [Abstract][Full Text] [Related]
27. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
Yordanova YN; Moritz-Gasser S; Duffau H
J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
[TBL] [Abstract][Full Text] [Related]
28. The effect of operations in patients with recurrent diffuse low-grade glioma: A qualitative systematic review.
Chang J; Wang Y; Guo R; Guo X; Lu Y; Ma W; Wang R
Clin Neurol Neurosurg; 2020 Sep; 196():105973. PubMed ID: 32610264
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative 3D ultrasound-guided resection of diffuse low-grade gliomas: radiological and clinical results.
Bø HK; Solheim O; Kvistad KA; Berntsen EM; Torp SH; Skjulsvik AJ; Reinertsen I; Iversen DH; Unsgård G; Jakola AS
J Neurosurg; 2019 Feb; 132(2):518-529. PubMed ID: 30717057
[TBL] [Abstract][Full Text] [Related]
30. Surgical management of incidentally discovered diffusely infiltrating low-grade glioma.
Opoku-Darko M; Lang ST; Artindale J; Cairncross JG; Sevick RJ; Kelly JJP
J Neurosurg; 2018 Jul; 129(1):19-26. PubMed ID: 28984519
[TBL] [Abstract][Full Text] [Related]
31. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
32. Perioperative outcomes following reoperation for recurrent insular gliomas.
Morshed RA; Young JS; Han SJ; Hervey-Jumper SL; Berger MS
J Neurosurg; 2018 Sep; 131(2):467-473. PubMed ID: 30239317
[TBL] [Abstract][Full Text] [Related]
33. Repeated operations for infiltrative low-grade gliomas without intervening therapy.
Schmidt MH; Berger MS; Lamborn KR; Aldape K; McDermott MW; Prados MD; Chang SM
J Neurosurg; 2003 Jun; 98(6):1165-9. PubMed ID: 12816258
[TBL] [Abstract][Full Text] [Related]
34. Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature.
Albuquerque LAF; Almeida JP; de Macêdo Filho LJM; Joaquim AF; Duffau H
Neurosurg Rev; 2021 Jun; 44(3):1371-1389. PubMed ID: 32770298
[TBL] [Abstract][Full Text] [Related]
35. Feasibility of fluorescence-guided resection of recurrent gliomas using five-aminolevulinic acid: retrospective analysis of surgical and neurological outcome in 58 patients.
Hickmann AK; Nadji-Ohl M; Hopf NJ
J Neurooncol; 2015 Mar; 122(1):151-60. PubMed ID: 25557106
[TBL] [Abstract][Full Text] [Related]
36. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
Eseonu CI; ReFaey K; Garcia O; Raghuraman G; Quinones-Hinojosa A
World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
[TBL] [Abstract][Full Text] [Related]
37. Impact of Resection on Survival of Isocitrate Dehydrogenase 1-Mutated World Health Organization Grade II Astrocytoma After Malignant Progression.
Grau SJ; Hampl JA; Kohl AC; Timmer M; Duval IV; Blau T; Ruge MI; Goldbrunner RH
World Neurosurg; 2017 Jul; 103():180-185. PubMed ID: 28377251
[TBL] [Abstract][Full Text] [Related]
38. Residual Tumor Volume as Best Outcome Predictor in Low Grade Glioma - A Nine-Years Near-Randomized Survey of Surgery vs. Biopsy.
Roelz R; Strohmaier D; Jabbarli R; Kraeutle R; Egger K; Coenen VA; Weyerbrock A; Reinacher PC
Sci Rep; 2016 Aug; 6():32286. PubMed ID: 27574036
[TBL] [Abstract][Full Text] [Related]
39. High Grade Glioma Surgery - Clinical Aspects and Prognosis.
Mladenovsk M; Valkov I; Ovcharov M; Vasilev N; Duhlenski I
Folia Med (Plovdiv); 2021 Feb; 63(1):35-41. PubMed ID: 33650394
[TBL] [Abstract][Full Text] [Related]
40. Comparative volumetric analysis of the extent of resection of molecularly and histologically distinct low grade gliomas and its role on survival.
Eseonu CI; Eguia F; ReFaey K; Garcia O; Rodriguez FJ; Chaichana K; Quinones-Hinojosa A
J Neurooncol; 2017 Aug; 134(1):65-74. PubMed ID: 28527004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
